# active_site_0120

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **B** — Position 283 (Proton donor/acceptor)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | reasoning-supported | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MASSDLEAATALKVQGNKAFGQHEWPTAVDFYTQAIAKYDREPSFFSNRAQAHIKLEAYGFAIADATKALELDPAYTKAYWRRALANTAILNYKDALRDFKVVAKREPNNRDAKVKLADCEKLVRRMEFEKAIEVGDPPSAFEDLDIDAIAVDDSYDGVRLEKEMTQEFIDDMIERFKNGKKIHRKYAFQIVKAVKDIVYAEPTMVEIGVDQGTKLTVCGDTHGQFFDLLEIFRLNGYPSEKHAYLFNGDFVDRGSWSTEIALLLYAYKWLRPNGIFLNRGNHETDDMNKVYGFEGECKAKYNERMFKVFSESFSALPLATLIGNKYLVLHGGLFSDDNTSLDDIRKLDRHNQRQPGQQGLMMEMLWTDPQTEPGRGPSKRGVGLQFGPDVTKRFCEKNGLEAIIRSHEVRMEGYEVEHDGRCITVFSAPKYCDTTENKGAFINVGPELKLDFQVFEAVPHPDIKPMAYAQNSIMSMM

[Multiple Choices]
A. Position 975 (Proton acceptor; for dehydratase activity)
B. Position 283 (Proton donor/acceptor)
C. Position 1142 (Proton donor; for dehydratase activity 1)
D. Position 58 (Proton donor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the cited UniProt entry, which annotates position 283 as an active-site proton donor/acceptor. The annotation is computationally inferred from a PIRSR signature, not direct experimental confirmation in the supplied evidence.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is 478 residues long, excluding positions 975 and 1142. Position 58 is alanine, which is not a plausible proton donor; position 283 is histidine, whose side chain can donate or accept a proton. The phosphatase-like sequence context makes the histidine a biologically plausible catalytic candidate.


**Missing item-specific fact**

> Confirming that His283 is specifically annotated as an active-site residue, rather than merely a plausible catalytic candidate, requires protein-specific evidence.


**Reason**

> The sequence and choices provide a meaningful chemical and length-based distinction favoring B, though they do not independently establish the precise active-site assignment.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the listed options, only position 283 is both within the sequence and consistent with the stated proton donor/acceptor role.


### Important caveats

- The reviewer-only annotation is computationally inferred by signature transfer; the supplied evidence does not establish direct experimental validation of His283.
- The question describes active-site residues plural, but each option lists only one position.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is 478 residues long, excluding positions 975 and 1142. Position 58 is alanine, which is not a plausible proton donor; position 283 is histidine, whose side chain can donate or accept a proton. The phosphatase-like sequence context makes the histidine a biologically plausible catalytic candidate.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Confirming that His283 is specifically annotated as an active-site residue, rather than merely a plausible catalytic candidate, requires protein-specific evidence.",
    "reason": "The sequence and choices provide a meaningful chemical and length-based distinction favoring B, though they do not independently establish the precise active-site assignment."
  },
  "case_id": "active_site_0120",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the cited UniProt entry, which annotates position 283 as an active-site proton donor/acceptor. The annotation is computationally inferred from a PIRSR signature, not direct experimental confirmation in the supplied evidence."
  },
  "important_caveats": [
    "The reviewer-only annotation is computationally inferred by signature transfer; the supplied evidence does not establish direct experimental validation of His283.",
    "The question describes active-site residues plural, but each option lists only one position."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed options, only position 283 is both within the sequence and consistent with the stated proton donor/acceptor role."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0120",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the cited UniProt entry, which annotates position 283 as an active-site proton donor/acceptor. The annotation is computationally inferred from a PIRSR signature, not direct experimental confirmation in the supplied evidence.",
    "evidence_ids": ["C1", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is 478 residues long, excluding positions 975 and 1142. Position 58 is alanine, which is not a plausible proton donor; position 283 is histidine, whose side chain can donate or accept a proton. The phosphatase-like sequence context makes the histidine a biologically plausible catalytic candidate.",
    "missing_item_specific_fact": "Confirming that His283 is specifically annotated as an active-site residue, rather than merely a plausible catalytic candidate, requires protein-specific evidence.",
    "reason": "The sequence and choices provide a meaningful chemical and length-based distinction favoring B, though they do not independently establish the precise active-site assignment."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed options, only position 283 is both within the sequence and consistent with the stated proton donor/acceptor role."
  },
  "important_caveats": [
    "The reviewer-only annotation is computationally inferred by signature transfer; the supplied evidence does not establish direct experimental validation of His283.",
    "The question describes active-site residues plural, but each option lists only one position."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry Q2U919 (Serine/threonine-protein phosphatase T, PPP5_ASPOR) annotates position 283 as ACT_SITE with description 'Proton donor/acceptor' (evidence ECO:0000255|PIRSR:PIRSR033096-1). The benchmark sequence (478 AA) matches the source sequence exactly (SHA256 confirmed). The annotation is present in both the current entry (v129) and the historical archived entry (v127). Note: the evidence code indicates computational inference by similarity to a PIRSF motif rather than direct experimental determination, but the PPP-family GD-motif catalytic mechanism is well-established. Options A (pos 975) and C (pos 1142) reference positions beyond the 478-residue protein length, making them trivially invalid.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C1](#evidence-c1), [C4](#evidence-c4), [C2](#evidence-c2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The protein is a PPP-family serine/threonine phosphatase (identifiable from conserved motifs such as the GD catalytic motif and metal-binding residues). PPP phosphatases catalyze hydrolysis via a conserved GD motif in the C-terminal catalytic domain, where the aspartate acts as both proton donor and acceptor. The N-terminal region (around position 58) corresponds to the TPR domain, which is a protein-protein interaction module, not the catalytic center. The 'proton donor/acceptor' description in option B matches the established PPP catalytic mechanism, whereas 'proton donor' alone (option D) is mechanistically incomplete. The GD motif ('CGDTHGQ') is identifiable in the sequence within the C-terminal catalytic domain region. Options A and C are eliminable by noting positions 975 and 1142 exceed the 478-residue protein length.


**Missing item-specific fact**

> Exact residue counting to confirm position 283 (vs. other positions in the C-terminal domain) is tedious without tools, though the GD motif's location in the catalytic domain provides strong positional reasoning. The specific PIRSF motif annotation (PIRSR033096-1) is not provided in the question.


**Reason**

> A model with knowledge of PPP-family phosphatase catalytic mechanism can reason that: (1) the GD motif is the catalytic center, (2) it resides in the C-terminal phosphatase domain not the N-terminal TPR domain, (3) the aspartate in GD serves as proton donor/acceptor. This meaningfully distinguishes B from D. Options A and C are eliminable by sequence-length arithmetic. The biological argument is concrete and grounded in well-established enzymology, though exact position numbering adds some difficulty.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and C are impossible (positions exceed protein length). Option D places the active site in the TPR domain, which is inconsistent with PPP-family catalytic architecture. Option B uniquely matches the annotated and mechanistically expected active site. No genuine ambiguity among defensible choices.


### Important caveats

- The active-site annotation relies on ECO:0000255 (similarity to PIRSF motif PIRSR033096-1), a computational inference, not direct experimental mutagenesis or crystallographic evidence for this specific protein.
- The reviewer-only evidence confirms sequence match and annotation presence, but the evaluated model did not have access to the UniProt entry or accession.
- The question asks for 'the enzyme's catalytic center' (singular), consistent with the single active-site annotation, though PPP phosphatases also require metal ions (Mn2+) and other residues for full activity.
- Exact position counting in a 478-aa sequence is error-prone for a language model without tools; the biological reasoning about domain architecture and GD motif location provides the primary discriminating logic.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The protein is a PPP-family serine/threonine phosphatase (identifiable from conserved motifs such as the GD catalytic motif and metal-binding residues). PPP phosphatases catalyze hydrolysis via a conserved GD motif in the C-terminal catalytic domain, where the aspartate acts as both proton donor and acceptor. The N-terminal region (around position 58) corresponds to the TPR domain, which is a protein-protein interaction module, not the catalytic center. The 'proton donor/acceptor' description in option B matches the established PPP catalytic mechanism, whereas 'proton donor' alone (option D) is mechanistically incomplete. The GD motif ('CGDTHGQ') is identifiable in the sequence within the C-terminal catalytic domain region. Options A and C are eliminable by noting positions 975 and 1142 exceed the 478-residue protein length.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Exact residue counting to confirm position 283 (vs. other positions in the C-terminal domain) is tedious without tools, though the GD motif's location in the catalytic domain provides strong positional reasoning. The specific PIRSF motif annotation (PIRSR033096-1) is not provided in the question.",
    "reason": "A model with knowledge of PPP-family phosphatase catalytic mechanism can reason that: (1) the GD motif is the catalytic center, (2) it resides in the C-terminal phosphatase domain not the N-terminal TPR domain, (3) the aspartate in GD serves as proton donor/acceptor. This meaningfully distinguishes B from D. Options A and C are eliminable by sequence-length arithmetic. The biological argument is concrete and grounded in well-established enzymology, though exact position numbering adds some difficulty."
  },
  "case_id": "active_site_0120",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C1",
      "C4",
      "C2"
    ],
    "judgment": "supported",
    "reason": "UniProt entry Q2U919 (Serine/threonine-protein phosphatase T, PPP5_ASPOR) annotates position 283 as ACT_SITE with description 'Proton donor/acceptor' (evidence ECO:0000255|PIRSR:PIRSR033096-1). The benchmark sequence (478 AA) matches the source sequence exactly (SHA256 confirmed). The annotation is present in both the current entry (v129) and the historical archived entry (v127). Note: the evidence code indicates computational inference by similarity to a PIRSF motif rather than direct experimental determination, but the PPP-family GD-motif catalytic mechanism is well-established. Options A (pos 975) and C (pos 1142) reference positions beyond the 478-residue protein length, making them trivially invalid."
  },
  "important_caveats": [
    "The active-site annotation relies on ECO:0000255 (similarity to PIRSF motif PIRSR033096-1), a computational inference, not direct experimental mutagenesis or crystallographic evidence for this specific protein.",
    "The reviewer-only evidence confirms sequence match and annotation presence, but the evaluated model did not have access to the UniProt entry or accession.",
    "The question asks for 'the enzyme's catalytic center' (singular), consistent with the single active-site annotation, though PPP phosphatases also require metal ions (Mn2+) and other residues for full activity.",
    "Exact position counting in a 478-aa sequence is error-prone for a language model without tools; the biological reasoning about domain architecture and GD motif location provides the primary discriminating logic."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are impossible (positions exceed protein length). Option D places the active site in the TPR domain, which is inconsistent with PPP-family catalytic architecture. Option B uniquely matches the annotated and mechanistically expected active site. No genuine ambiguity among defensible choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0120",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry Q2U919 (Serine/threonine-protein phosphatase T, PPP5_ASPOR) annotates position 283 as ACT_SITE with description 'Proton donor/acceptor' (evidence ECO:0000255|PIRSR:PIRSR033096-1). The benchmark sequence (478 AA) matches the source sequence exactly (SHA256 confirmed). The annotation is present in both the current entry (v129) and the historical archived entry (v127). Note: the evidence code indicates computational inference by similarity to a PIRSF motif rather than direct experimental determination, but the PPP-family GD-motif catalytic mechanism is well-established. Options A (pos 975) and C (pos 1142) reference positions beyond the 478-residue protein length, making them trivially invalid.",
    "evidence_ids": ["C5", "H3", "C1", "C4", "C2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The protein is a PPP-family serine/threonine phosphatase (identifiable from conserved motifs such as the GD catalytic motif and metal-binding residues). PPP phosphatases catalyze hydrolysis via a conserved GD motif in the C-terminal catalytic domain, where the aspartate acts as both proton donor and acceptor. The N-terminal region (around position 58) corresponds to the TPR domain, which is a protein-protein interaction module, not the catalytic center. The 'proton donor/acceptor' description in option B matches the established PPP catalytic mechanism, whereas 'proton donor' alone (option D) is mechanistically incomplete. The GD motif ('CGDTHGQ') is identifiable in the sequence within the C-terminal catalytic domain region. Options A and C are eliminable by noting positions 975 and 1142 exceed the 478-residue protein length.",
    "missing_item_specific_fact": "Exact residue counting to confirm position 283 (vs. other positions in the C-terminal domain) is tedious without tools, though the GD motif's location in the catalytic domain provides strong positional reasoning. The specific PIRSF motif annotation (PIRSR033096-1) is not provided in the question.",
    "reason": "A model with knowledge of PPP-family phosphatase catalytic mechanism can reason that: (1) the GD motif is the catalytic center, (2) it resides in the C-terminal phosphatase domain not the N-terminal TPR domain, (3) the aspartate in GD serves as proton donor/acceptor. This meaningfully distinguishes B from D. Options A and C are eliminable by sequence-length arithmetic. The biological argument is concrete and grounded in well-established enzymology, though exact position numbering adds some difficulty."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are impossible (positions exceed protein length). Option D places the active site in the TPR domain, which is inconsistent with PPP-family catalytic architecture. Option B uniquely matches the annotated and mechanistically expected active site. No genuine ambiguity among defensible choices."
  },
  "important_caveats": [
    "The active-site annotation relies on ECO:0000255 (similarity to PIRSF motif PIRSR033096-1), a computational inference, not direct experimental mutagenesis or crystallographic evidence for this specific protein.",
    "The reviewer-only evidence confirms sequence match and annotation presence, but the evaluated model did not have access to the UniProt entry or accession.",
    "The question asks for 'the enzyme's catalytic center' (singular), consistent with the single active-site annotation, though PPP phosphatases also require metal ions (Mn2+) and other residues for full activity.",
    "Exact position counting in a 478-aa sequence is error-prone for a language model without tools; the biological reasoning about domain architecture and GD motif location provides the primary discriminating logic."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `Q2U919` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 127. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2U919.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:21.139726+00:00.  

```json
"Q2U919"
```

Source SHA-256: `6676178685d6229700b2ed516c3ca232d2558330a425e199b609fbecba8e2b23`.

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2U919.json)  
**Locator:** `/entryAudit`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:21.139726+00:00.  

```json
{"entryVersion":129,"firstPublicDate":"2025-02-05","lastAnnotationUpdateDate":"2026-09-02","lastSequenceUpdateDate":"2006-01-24","sequenceVersion":1}
```

Source SHA-256: `6676178685d6229700b2ed516c3ca232d2558330a425e199b609fbecba8e2b23`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2U919.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:21.139726+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"17475320","source":"PubMed"}],"value":"AoPPT"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"17475320","source":"PubMed"}],"value":"3.1.3.16"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000250","id":"P53043","source":"UniProtKB"}],"value":"Serine/threonine-protein phosphatase T"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"P53043","source":"UniProtKB"}],"value":"PPT"}]}}
```

Source SHA-256: `6676178685d6229700b2ed516c3ca232d2558330a425e199b609fbecba8e2b23`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2U919.json)  
**Locator:** `/features/5`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:21.139726+00:00.  

```json
{"description":"Proton donor/acceptor","evidences":[{"evidenceCode":"ECO:0000255","id":"PIRSR033096-1","source":"PIRSR"}],"location":{"end":{"modifier":"EXACT","value":283},"start":{"modifier":"EXACT","value":283}},"type":"Active site"}
```

Source SHA-256: `6676178685d6229700b2ed516c3ca232d2558330a425e199b609fbecba8e2b23`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2U919?format=txt&versions=127)  
**Locator:** `lines 145-147`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 127 / 1.  
**Retrieved:** 2026-11-01T06:28:33.211950+00:00.  

```text
FT   ACT_SITE        283
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR033096-1"
```

Source SHA-256: `2651cbb7ccfd83249fbb6eae9366ac5480fd9278b87d40a7024c3dcc2b8c5a20`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 120. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
